These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 17582656

  • 1. Neuroprotective effects of short peptides derived from the Insulin-like growth factor 1.
    Górecki DC, Beresewicz M, Zabłocka B.
    Neurochem Int; 2007 Dec; 51(8):451-8. PubMed ID: 17582656
    [Abstract] [Full Text] [Related]

  • 2. Expression of IGF-1 isoforms after exercise-induced muscle damage in humans: characterization of the MGF E peptide actions in vitro.
    Philippou A, Papageorgiou E, Bogdanis G, Halapas A, Sourla A, Maridaki M, Pissimissis N, Koutsilieris M.
    In Vivo; 2009 Dec; 23(4):567-75. PubMed ID: 19567392
    [Abstract] [Full Text] [Related]

  • 3. A strong neuroprotective effect of the autonomous C-terminal peptide of IGF-1 Ec (MGF) in brain ischemia.
    Dluzniewska J, Sarnowska A, Beresewicz M, Johnson I, Srai SK, Ramesh B, Goldspink G, Górecki DC, Zabłocka B.
    FASEB J; 2005 Nov; 19(13):1896-8. PubMed ID: 16144956
    [Abstract] [Full Text] [Related]

  • 4. Neuroprotection against hypoxia-ischemia by insulin-like growth factor-I (IGF-I).
    Smith PF.
    IDrugs; 2003 Dec; 6(12):1173-7. PubMed ID: 14666428
    [Abstract] [Full Text] [Related]

  • 5. A new pro-migratory activity on human myogenic precursor cells for a synthetic peptide within the E domain of the mechano growth factor.
    Mills P, Lafrenière JF, Benabdallah BF, El Fahime el M, Tremblay JP.
    Exp Cell Res; 2007 Feb 01; 313(3):527-37. PubMed ID: 17156777
    [Abstract] [Full Text] [Related]

  • 6. The role of the insulin-like growth factor 1 (IGF-1) in skeletal muscle physiology.
    Philippou A, Maridaki M, Halapas A, Koutsilieris M.
    In Vivo; 2007 Feb 01; 21(1):45-54. PubMed ID: 17354613
    [Abstract] [Full Text] [Related]

  • 7. Protective and regenerative effects of the GH/IGF-I axis on the brain.
    Isgaard J, Aberg D, Nilsson M.
    Minerva Endocrinol; 2007 Jun 01; 32(2):103-13. PubMed ID: 17557036
    [Abstract] [Full Text] [Related]

  • 8. Type I insulin-like growth factor receptor signaling in skeletal muscle regeneration and hypertrophy.
    Philippou A, Halapas A, Maridaki M, Koutsilieris M.
    J Musculoskelet Neuronal Interact; 2007 Jun 01; 7(3):208-18. PubMed ID: 17947802
    [Abstract] [Full Text] [Related]

  • 9. Age-related muscle loss and progressive dysfunction in mechanosensitive growth factor signaling.
    Goldspink G.
    Ann N Y Acad Sci; 2004 Jun 01; 1019():294-8. PubMed ID: 15247032
    [Abstract] [Full Text] [Related]

  • 10. Insulin-like growth factor-I E peptides: implications for aging skeletal muscle.
    Velloso CP, Harridge SD.
    Scand J Med Sci Sports; 2010 Feb 01; 20(1):20-7. PubMed ID: 19883387
    [Abstract] [Full Text] [Related]

  • 11. Neuronal activity drives localized blood-brain-barrier transport of serum insulin-like growth factor-I into the CNS.
    Nishijima T, Piriz J, Duflot S, Fernandez AM, Gaitan G, Gomez-Pinedo U, Verdugo JM, Leroy F, Soya H, Nuñez A, Torres-Aleman I.
    Neuron; 2010 Sep 09; 67(5):834-46. PubMed ID: 20826314
    [Abstract] [Full Text] [Related]

  • 12. IGF-IEc expression, regulation and biological function in different tissues.
    Dai Z, Wu F, Yeung EW, Li Y.
    Growth Horm IGF Res; 2010 Aug 09; 20(4):275-81. PubMed ID: 20494600
    [Abstract] [Full Text] [Related]

  • 13. Reconciling data from transgenic mice that overexpress IGF-I specifically in skeletal muscle.
    Shavlakadze T, Winn N, Rosenthal N, Grounds MD.
    Growth Horm IGF Res; 2005 Feb 09; 15(1):4-18. PubMed ID: 15701567
    [Abstract] [Full Text] [Related]

  • 14. Alternatively spliced transcripts of Sparus aurata insulin-like growth factor 1 are differentially expressed in adult tissues and during early development.
    Tiago DM, Laizé V, Cancela ML.
    Gen Comp Endocrinol; 2008 Jun 09; 157(2):107-15. PubMed ID: 18555066
    [Abstract] [Full Text] [Related]

  • 15. [Variational structure and function of products from IGF-1 gene].
    Zhang BB, Wang YL, Fan K.
    Sheng Li Ke Xue Jin Zhan; 2008 Jul 09; 39(3):209-13. PubMed ID: 18819487
    [Abstract] [Full Text] [Related]

  • 16. Signaling by insulin-like growth factor 1 in brain.
    Bondy CA, Cheng CM.
    Eur J Pharmacol; 2004 Apr 19; 490(1-3):25-31. PubMed ID: 15094071
    [Abstract] [Full Text] [Related]

  • 17. Autoradiographic and immunohistochemical localization of insulin-like growth factor-I receptor binding sites in brain of the brown trout, Salmo trutta.
    Smith A, Chan SJ, Gutiérrez J.
    Gen Comp Endocrinol; 2005 May 01; 141(3):203-13. PubMed ID: 15804507
    [Abstract] [Full Text] [Related]

  • 18. Intermittent high glucose concentrations reduce neuronal precursor survival by altering the IGF system: the involvement of the neuroprotective factor DHCR24 (Seladin-1).
    Giannini S, Benvenuti S, Luciani P, Manuelli C, Cellai I, Deledda C, Pezzatini A, Vannelli GB, Maneschi E, Rotella CM, Serio M, Peri A.
    J Endocrinol; 2008 Sep 01; 198(3):523-32. PubMed ID: 18612048
    [Abstract] [Full Text] [Related]

  • 19. Insulin-like growth factor-I activation of Akt survival cascade in neuronal cells requires the presence of its cognate receptor in caveolae.
    Lu X, Kambe F, Cao X, Yamauchi M, Seo H.
    Exp Cell Res; 2008 Jan 15; 314(2):342-51. PubMed ID: 18022157
    [Abstract] [Full Text] [Related]

  • 20. PEGylation enhances the therapeutic potential for insulin-like growth factor I in central nervous system disorders.
    Saenger S, Goeldner C, Frey JR, Ozmen L, Ostrowitzki S, Spooren W, Ballard TM, Prinssen E, Borroni E, Metzger F.
    Growth Horm IGF Res; 2011 Oct 15; 21(5):292-303. PubMed ID: 21865068
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.